... from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Darolutamide Metastatic castration-resistant prostate cancer Docetaxel Androgen deprivation therapy Prostate-specific antigen Prostate cancer (PCa) is the most predominant solid...

...Radion Garaz; Arnulf Stenzl; Stephan Singer; Sven Mattern; Jens Bedke; Bastian Amend Introduction: We report a rare case of Skene’s gland hyperplasia where the serum prostate-specific antigen (PSA) level was measurable. Case Presentation: The patient was a 91-year-old woman with a suspected bladder...

... hyperplasia (BPH) ( n = 155) were included in the BPH group, while all patients with PCa ( n = 49) were enrolled in the PCa group. Between the groups, the serum concentrations of total prostate-specific antigen (TPSA), percent-free prostate-specific antigen (%fPSA), prostate health index (PHI), prostate...

... prostatectomy and extended pelvic lymph node dissection. Materials and Methods: Density measurements included the ratio of endogenous testosterone (ET), prostate-specific antigen (PSA), and percentage of biopsy positive cores (BPC) on prostate volume (ETD, PSAD, and BPCD, respectively). The ratio of percentage...

...Robert Peters; Carsten Stephan; Klaus Jung; Michael Lein; Frank Friedersdorff; Andreas Maxeiner Background: Beyond prostate-specific antigen (PSA), other biomarkers for prostate cancer (PCa) detection are available and need to be evaluated for clinical routine. Objective: The aim of the study...

.... Magnetic resonance imaging Transrectal ultrasound Benign prostatic hyperplasia Digital rectal examination Prostate-specific antigen Prostate volume In order to correctly evaluate and manage prostatic diseases, such as benign prostatic hypertrophy (BPH) and prostate cancer (PCa...

...Matthew B. Clements; Basil Abdalla; Stephen H. Culp; Raymond A. Costabile; Tracey L. Krupski Background: In May 2012, the US Preventive Services Task Force assigned prostate-specific antigen-based screening a grade D recommendation, advising against screening at any age. Our objective...

...; indeed, after this point, the risk curve increases abruptly reaching the proportion rate of 0.80 as PSA increase till 10 ng/mL. PCI, prostatic chronic inflammation; DRE, digital rectal examination; PSA, prostatic-specific antigen. Fig. 2. Probability model predicting the risk of PCI by baseline PSA...

... (Group 2), NCACT was also divided into 2 groups as PCal presence (PCal+) and lack (PCal–) serum UA, calcium, phosphorus, sodium, prostate-specific antigen levels and urinary analysis results of the patients were evaluated and compared. Results: PCal were detected in 38 of 169 patients (22%). PCal...

..., PSM were detected in 149 cases (31.3%), which included 99 patients with focal cancer invasion (20.8%) and 50 subjects with multifocal cancer invasion (10.5%). In univariate analysis, PSM associated with higher median levels of TT and prostate-specific antigen than controls. Multifocal PSM associated...

... < 0.0001), prostate specific antigen (OR 1.167; p < 0.0001), and abnormal digital rectal examination (OR 2.251; p < 0.0001) but inversely with TPV (OR 0.921; p < 0.0001) and PCI (OR 0.106; p < 0.0001). Conclusions: PCI decreased the risk of PCA among ISUP tumor grade groups. dr.porcaro...

... of 5-year BCR showed an optimal agreement between the prediction by nomogram and actual observation (Fig.  5 b). Fig. 5. a Nomogram to predict the probability of biochemical recurrence (BcR) at 5-year following radical prostectomy (RP) for patient with persistent prostate-specific antigen (PSA...

...Angeles Sanchis-Bonet; Marta Barrionuevo-González; Ana Bajo-Chueca; Nelson Morales-Palacios; Manuel Sanchez-Chapado Introduction: To assess whether [-2]pro-prostate-specific antigen (p2PSA) meets the criteria to justify its inclusion in a predictive model of prostate cancer (PCa) diagnosis...

... associated with LNI were prostate-specific antigen (PSA) and proportion of positive cores. The main model showed that only higher values of PSA increased the odds of bilateral LNI when compared to patients having unilateral LNI (OR 1.058; p = 0.018). The area under the curve of PSA predicting bilateral LNI...

...Hoon Choi; Seok Cho; Jae Hyun Bae; Sang Eun Lee; Sung Kyu Hong; Du Geon Moon; Jun Cheon; Seok-Soo Byun; Jae Young Park Background/Aims/Objectives: We studied the detection rate of prostate cancer (PCa) among Korean men with a prostate-specific antigen (PSA) level of less than 4.0 ng/mL. Methods...

... included TT (OR 1.058; p = 0.027) and prostate-specific antigen (PSA) density (OR 23.3; p = 0.008) as well as TT (OR 1.057; p = 0.029) with PSA (OR 1.061; p = 0.023). The model suggests that 1 unit increase in TT plasma levels increases the odds of bGS upgrading by 5.8 or 5.7%. Conclusions: In summary, we...

... prostate cancer (PC), active or opportunistic screening based on the prostate-specific antigen (PSA) leads to a significant number of patients demonstrating organ-confined or low-risk disease [ 1 ]. In this context, overdiagnosis leading to overtreatment is an important adverse effect of such diagnostic...

..., prostate-specific antigen (PSA) >20 μg/ml and metastases. The PCA detection rate was 41.1%. PVI was a negative independent predictor of PCA. A PVI ≤1.0 was directly [odds ratio (OR) = 2.36] associated with PCA, which was detected more frequently in patients with a PVI ≤1.0 (29.1%) than in those...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate cancer Biopsy Biomarker Prostate-specific antigen proPSA Prostate-specific antigen isoform In Europe, prostate cancer (PCa...

... Gleason score (pGS). Materials and Methods: Pretreatment and pathological variables of 220 patients operated with radical prostatectomy were retrospectively reviewed. Age, prostate-specific antigen (PSA), percentage of positive biopsy cores (P+), biopsy Gleason score (bGS), pGS, TT and free testosterone...